Patent · US Active

Pyrimidines as sodium channel blockers

US9656968B2 · kind B2 · utility

2Cited by
27References
14Claims
0Family size

Inventors

Key dates

Filing dateSep 23, 2015
Grant dateMay 23, 2017
Priority date
Expiry dateSep 23, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/506
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides substituted pyrimidine compounds of Formula (I), and the pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein A1, X, A2, W1, W2, W3, E, Z, and R4 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.